Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Nepal · SciRah

Researcher profile · Semantic Scholar

S. Nepal

Share profile

S. Nepal — researcher profile on SciRah

h-index: 9
Works: 26
Citations: 1,365

Most-cited papers

Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
Charles E. Frost, Jessie Wang, S. Nepal, A. Schuster +4 more
2012British Journal of Clinical Pharmacology388 citations Open access
Semantic Scholar
Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes
J. Rosenstock, C. Aguilar-Salinas, E. Klein, S. Nepal +2 more
2009Current Medical Research and Opinion310 citations
Semantic Scholar
Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.
Charles E. Frost, S. Nepal, Jessie Wang, A. Schuster +7 more
2013British Journal of Clinical Pharmacology298 citations Open access
Semantic Scholar
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +29 more
2013Circulation214 citations Open access
Semantic Scholar
Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
W. Byon, S. Nepal, A. Schuster, A. Shenker +1 more
2018Journal of clinical pharmacology48 citations
Semantic Scholar
Poor And Unsatisfactory Disposal Of Expired And Unused Pharmaceuticals: A Global Issue.
S. Nepal, A. Giri, R. Bhandari, Sharad Chand +5 more
2020Current Drug Safety32 citations
Semantic Scholar
The effect of itraconazole on the pharmacokinetics of lorlatinib: results of a phase I, open-label, crossover study in healthy participants
Maulik Patel, Joseph Chen, S. Mcgrory, M. O’Gorman +3 more
2019Investigational new drugs24 citations
Semantic Scholar
Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants
Jennifer E. Hibma, M. O’Gorman, S. Nepal, Sylvester Pawlak +2 more
2021Cancer Chemotherapy and Pharmacology12 citations Open access
Semantic Scholar
Efficacy and Safety of Apixaban Compared with Warfarin at Different Levels of Predicted INR Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +34 more
201311 citations
Semantic Scholar
Phase 1 Study Evaluating the Effects of the Proton Pump Inhibitor Rabeprazole and Food on the Pharmacokinetics of Lorlatinib in Healthy Participants
Huiping Xu, M. O’Gorman, S. Nepal, Lee P. James +2 more
2021Clinical pharmacology in drug development7 citations Open access
Semantic Scholar
Randomized, blinded, placebo‐ and positive‐controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval
Charles E. Frost, S. Nepal, W. Byon, K. T. Moore +3 more
2015Journal of clinical pharmacology6 citations
Semantic Scholar
Impact of COVID-19 on Mental Dimension of Health: A Sensitive Issue to be Addressed at the Earliest
S. Nepal, S. Nepal, C. Shastry, Sharad Chand +4 more
20214 citations
Semantic Scholar
Outdated and unused medicines disposal practice among the undergraduate paramedical students – a pharmacist's intervention
S. Nepal, Anil Giri, C. Shastry, S. Chand +3 more
20204 citations
Semantic Scholar
No Clinical Impact of CYP3A5 Gene Polymorphisms on the Pharmacokinetics and/or Efficacy of Maraviroc in Healthy Volunteers and HIV‐1–Infected Subjects
M. Vourvahis, L. Mcfadyen, S. Nepal, S. Valluri +11 more
2018Journal of clinical pharmacology4 citations Open access
Semantic Scholar
Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects
R. Abbas, S. Riley, S. Nepal, M. Bachinsky +3 more
2021Clinical pharmacology in drug development3 citations
Semantic Scholar
An Open-label, Single-dose, Pharmacokinetic Study of Factor VIII Activity After Administration of Moroctocog Alfa (AF-CC) in Male Chinese Patients With Hemophilia A.
Hong-Zhong Liu, Run-Hui Wu, P. Hu, Fei-Fei Sun +6 more
2017Clinical Therapeutics3 citations
Semantic Scholar
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation".
L. Wallentin, R. Lopes, Michael S. Hanna, Laine E. Thomas +29 more
2014Circulation1 citations Open access
Semantic Scholar
tolerability, Pharmacokinetics and Pharmacodynamics of Apixaban, Aspirin and Clopidogrel Following Coadministration in Healthy Subjects : 2-54-2000057
Charles E. Frost, Zhigang Yu, P. Wastall, S. Nepal +2 more
20141 citations
Semantic Scholar
Correction to: Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants
Jennifer E. Hibma, M. O’Gorman, S. Nepal, Sylvester Pawlak +2 more
2022Cancer Chemotherapy and Pharmacology0 citations Open access
Semantic Scholar
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +29 more
20130 citations
Semantic Scholar
Efficacy and Safety of Apixaban Compared with Warfarin at Different Levels of Predicted INR Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +34 more
20130 citations
Semantic Scholar
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +29 more
20130 citations
Semantic Scholar
Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +29 more
20130 citations
Semantic Scholar
Efficacy and Safety of Apixaban Compared with Warfarin at Different Levels of Predicted INR Control for Stroke Prevention in Atrial Fibrillation
L. Wallentin, R. Lopes, M. Hanna, L. Thomas +34 more
20130 citations
Semantic Scholar
Lack of pharmacokinetic interaction between muraglitazar, a novel dual PPAR α/γ agonist, and fenofibrate
Rogelio Mosqueda-Garcia, D. Reitberg, C. Munsick, R. Darbenzio +3 more
20050 citations
Semantic Scholar
Muraglitazar does not alter the pharmacokinetics and pharmacodynamics of concomitantly administered warfarin in healthy subjects
A. Swaminathan, Charles E. Frost, S. Nepal, Ralph H. Raymond +3 more
20050 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Hylek×8
Invite
E. Hylek — researcher profile on SciRah
S. Al-Khatib×8
Invite
S. Al-Khatib — researcher profile on SciRah
M. Alings×8
Invite
M. Alings — researcher profile on SciRah
V. Harjola×8
Invite
V. Harjola — researcher profile on SciRah

×8

Invite

M. Keltai — researcher profile on SciRah

Invite

F. Lanas — researcher profile on SciRah

D. Vinereanu×8

Invite

D. Vinereanu — researcher profile on SciRah

Invite

M. Hanna — researcher profile on SciRah

Invite

L. Thomas — researcher profile on SciRah

Invite

J. Amerena — researcher profile on SciRah

Invite

J. Ansell — researcher profile on SciRah

Invite

P. Aylward — researcher profile on SciRah